Annual Total Liabilities
$82.43 M
-$185.12 M-69.19%
31 December 2023
Summary:
Sangamo Therapeutics annual total liabilities is currently $82.43 million, with the most recent change of -$185.12 million (-69.19%) on 31 December 2023. During the last 3 years, it has fallen by -$358.75 million (-81.32%). SGMO annual total liabilities is now -81.32% below its all-time high of $441.18 million, reached on 31 December 2020.SGMO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$72.13 M
+$2.81 M+4.05%
30 September 2024
Summary:
Sangamo Therapeutics quarterly total liabilities is currently $72.13 million, with the most recent change of +$2.81 million (+4.05%) on 30 September 2024. Over the past year, it has dropped by -$12.65 million (-14.92%). SGMO quarterly total liabilities is now -83.71% below its all-time high of $442.83 million, reached on 30 September 2020.SGMO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGMO Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -69.2% | -14.9% |
| 3 y3 years | -81.3% | -80.3% |
| 5 y5 years | -63.1% | -67.3% |
SGMO Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -81.3% | at low | -80.3% | +4.0% |
| 5 y | 5 years | -81.3% | at low | -83.7% | +4.0% |
| alltime | all time | -81.3% | >+9999.0% | -83.7% | +7782.9% |
Sangamo Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $72.13 M(+4.0%) |
| June 2024 | - | $69.32 M(-4.1%) |
| Mar 2024 | - | $72.26 M(-12.3%) |
| Dec 2023 | $82.43 M(-69.2%) | $82.43 M(-2.8%) |
| Sept 2023 | - | $84.78 M(-7.3%) |
| June 2023 | - | $91.43 M(-12.9%) |
| Mar 2023 | - | $104.96 M(-60.8%) |
| Dec 2022 | $267.55 M(-22.8%) | $267.55 M(-6.0%) |
| Sept 2022 | - | $284.76 M(-4.7%) |
| June 2022 | - | $298.85 M(-6.5%) |
| Mar 2022 | - | $319.79 M(-7.7%) |
| Dec 2021 | $346.58 M(-21.4%) | $346.58 M(-5.4%) |
| Sept 2021 | - | $366.38 M(-6.0%) |
| June 2021 | - | $389.91 M(-4.4%) |
| Mar 2021 | - | $407.68 M(-7.6%) |
| Dec 2020 | $441.18 M(+115.4%) | $441.18 M(-0.4%) |
| Sept 2020 | - | $442.83 M(+15.5%) |
| June 2020 | - | $383.45 M(+102.0%) |
| Mar 2020 | - | $189.86 M(-7.3%) |
| Dec 2019 | $204.78 M(-8.2%) | $204.78 M(-7.3%) |
| Sept 2019 | - | $220.89 M(-3.0%) |
| June 2019 | - | $227.73 M(+6.6%) |
| Mar 2019 | - | $213.55 M(-4.3%) |
| Dec 2018 | $223.14 M(+125.8%) | $223.14 M(-1.6%) |
| Sept 2018 | - | $226.70 M(-5.5%) |
| June 2018 | - | $239.86 M(+142.8%) |
| Mar 2018 | - | $98.80 M(-0.0%) |
| Dec 2017 | $98.84 M(+355.6%) | $98.84 M(+18.9%) |
| Sept 2017 | - | $83.14 M(-6.5%) |
| June 2017 | - | $88.95 M(+321.0%) |
| Mar 2017 | - | $21.13 M(-2.6%) |
| Dec 2016 | $21.70 M(-12.5%) | $21.70 M(+2.6%) |
| Sept 2016 | - | $21.14 M(+1.2%) |
| June 2016 | - | $20.88 M(+18.4%) |
| Mar 2016 | - | $17.64 M(-28.9%) |
| Dec 2015 | $24.80 M(-32.2%) | $24.80 M(-14.4%) |
| Sept 2015 | - | $28.96 M(-3.5%) |
| June 2015 | - | $30.00 M(-3.3%) |
| Mar 2015 | - | $31.02 M(-15.2%) |
| Dec 2014 | $36.58 M(+91.2%) | $36.58 M(-1.7%) |
| Sept 2014 | - | $37.21 M(+2.0%) |
| June 2014 | - | $36.48 M(-4.2%) |
| Mar 2014 | - | $38.08 M(+99.1%) |
| Dec 2013 | $19.13 M(+8.5%) | $19.13 M(+34.5%) |
| Sept 2013 | - | $14.22 M(-4.0%) |
| June 2013 | - | $14.82 M(+3.9%) |
| Mar 2013 | - | $14.26 M(-19.2%) |
| Dec 2012 | $17.64 M(+144.8%) | $17.64 M(+14.4%) |
| Sept 2012 | - | $15.41 M(-4.2%) |
| June 2012 | - | $16.08 M(-0.0%) |
| Mar 2012 | - | $16.08 M(+123.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $7.20 M(+1.6%) | $7.20 M(+73.8%) |
| Sept 2011 | - | $4.14 M(+3.4%) |
| June 2011 | - | $4.01 M(+18.7%) |
| Mar 2011 | - | $3.38 M(-52.4%) |
| Dec 2010 | $7.09 M(-54.7%) | $7.09 M(+66.9%) |
| Sept 2010 | - | $4.25 M(+16.9%) |
| June 2010 | - | $3.64 M(-61.1%) |
| Mar 2010 | - | $9.34 M(-40.3%) |
| Dec 2009 | $15.66 M(+25.7%) | $15.66 M(+125.8%) |
| Sept 2009 | - | $6.93 M(-10.7%) |
| June 2009 | - | $7.76 M(-28.7%) |
| Mar 2009 | - | $10.89 M(-12.6%) |
| Dec 2008 | $12.45 M(+5.7%) | $12.45 M(-15.4%) |
| Sept 2008 | - | $14.73 M(-3.9%) |
| June 2008 | - | $15.32 M(+49.0%) |
| Mar 2008 | - | $10.29 M(-12.7%) |
| Dec 2007 | $11.78 M(+66.5%) | $11.78 M(+12.0%) |
| Sept 2007 | - | $10.52 M(+50.2%) |
| June 2007 | - | $7.00 M(+6.2%) |
| Mar 2007 | - | $6.59 M(-6.8%) |
| Dec 2006 | $7.08 M(-36.7%) | $7.08 M(-3.9%) |
| Sept 2006 | - | $7.36 M(-3.9%) |
| June 2006 | - | $7.66 M(-9.6%) |
| Mar 2006 | - | $8.47 M(-24.1%) |
| Dec 2005 | $11.17 M(+375.7%) | $11.17 M(+406.5%) |
| Sept 2005 | - | $2.21 M(+55.7%) |
| June 2005 | - | $1.42 M(-19.7%) |
| Mar 2005 | - | $1.76 M(-24.9%) |
| Dec 2004 | $2.35 M(+49.5%) | $2.35 M(+69.0%) |
| Sept 2004 | - | $1.39 M(+33.2%) |
| June 2004 | - | $1.04 M(+14.0%) |
| Mar 2004 | - | $915.00 K(-41.8%) |
| Dec 2003 | $1.57 M(-20.7%) | $1.57 M(-27.4%) |
| Sept 2003 | - | $2.16 M(+24.7%) |
| June 2003 | - | $1.74 M(+35.7%) |
| Mar 2003 | - | $1.28 M(-35.4%) |
| Dec 2002 | $1.98 M(-25.7%) | $1.98 M(+35.1%) |
| Sept 2002 | - | $1.47 M(-5.5%) |
| June 2002 | - | $1.55 M(-23.6%) |
| Mar 2002 | - | $2.03 M(-23.9%) |
| Dec 2001 | $2.67 M(+31.1%) | $2.67 M(+8.1%) |
| Sept 2001 | - | $2.47 M(+118.4%) |
| June 2001 | - | $1.13 M(-45.8%) |
| Mar 2001 | - | $2.08 M(+2.4%) |
| Dec 2000 | $2.04 M(+56.5%) | $2.04 M(+121.0%) |
| Sept 2000 | - | $921.00 K(-14.5%) |
| June 2000 | - | $1.08 M(-92.4%) |
| Mar 2000 | - | $14.09 M |
| Dec 1999 | $1.30 M(+107.0%) | - |
| Dec 1998 | $628.00 K(+29.0%) | - |
| Dec 1997 | $487.00 K(+363.8%) | - |
| Dec 1996 | $105.00 K | - |
FAQ
- What is Sangamo Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Sangamo Therapeutics?
- What is Sangamo Therapeutics annual total liabilities year-on-year change?
- What is Sangamo Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Sangamo Therapeutics?
- What is Sangamo Therapeutics quarterly total liabilities year-on-year change?
What is Sangamo Therapeutics annual total liabilities?
The current annual total liabilities of SGMO is $82.43 M
What is the all time high annual total liabilities for Sangamo Therapeutics?
Sangamo Therapeutics all-time high annual total liabilities is $441.18 M
What is Sangamo Therapeutics annual total liabilities year-on-year change?
Over the past year, SGMO annual total liabilities has changed by -$185.12 M (-69.19%)
What is Sangamo Therapeutics quarterly total liabilities?
The current quarterly total liabilities of SGMO is $72.13 M
What is the all time high quarterly total liabilities for Sangamo Therapeutics?
Sangamo Therapeutics all-time high quarterly total liabilities is $442.83 M
What is Sangamo Therapeutics quarterly total liabilities year-on-year change?
Over the past year, SGMO quarterly total liabilities has changed by -$12.65 M (-14.92%)